JP6149088B2 - 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 - Google Patents
消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 Download PDFInfo
- Publication number
- JP6149088B2 JP6149088B2 JP2015214004A JP2015214004A JP6149088B2 JP 6149088 B2 JP6149088 B2 JP 6149088B2 JP 2015214004 A JP2015214004 A JP 2015214004A JP 2015214004 A JP2015214004 A JP 2015214004A JP 6149088 B2 JP6149088 B2 JP 6149088B2
- Authority
- JP
- Japan
- Prior art keywords
- absorbent product
- diol
- pentane
- absorbent
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 title claims description 47
- 239000000203 mixture Substances 0.000 title description 21
- 239000002781 deodorant agent Substances 0.000 title description 3
- 239000002250 absorbent Substances 0.000 claims description 62
- 230000002745 absorbent Effects 0.000 claims description 62
- 235000019645 odor Nutrition 0.000 claims description 47
- 150000002009 diols Chemical class 0.000 claims description 43
- 210000002700 urine Anatomy 0.000 claims description 20
- 208000005230 Leg Ulcer Diseases 0.000 claims description 13
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 13
- 210000003608 fece Anatomy 0.000 claims description 13
- 206010040943 Skin Ulcer Diseases 0.000 claims description 12
- 239000008280 blood Substances 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 12
- 210000001124 body fluid Anatomy 0.000 claims description 12
- 239000010839 body fluid Substances 0.000 claims description 12
- 210000000416 exudates and transudate Anatomy 0.000 claims description 12
- 241000124008 Mammalia Species 0.000 claims description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 9
- 230000006835 compression Effects 0.000 claims description 7
- 238000007906 compression Methods 0.000 claims description 7
- 230000005906 menstruation Effects 0.000 claims description 7
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- -1 aminoglycoside Chemical compound 0.000 claims description 5
- 206010021639 Incontinence Diseases 0.000 claims description 4
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims description 3
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
- 229940123208 Biguanide Drugs 0.000 claims description 3
- 229930186147 Cephalosporin Natural products 0.000 claims description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 102000002068 Glycopeptides Human genes 0.000 claims description 3
- 108010015899 Glycopeptides Proteins 0.000 claims description 3
- 229930182555 Penicillin Natural products 0.000 claims description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 3
- 229920002413 Polyhexanide Polymers 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 239000004098 Tetracycline Substances 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 229960004150 aciclovir Drugs 0.000 claims description 3
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 3
- 229940072056 alginate Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229940126575 aminoglycoside Drugs 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 claims description 3
- 229960003644 aztreonam Drugs 0.000 claims description 3
- 150000004283 biguanides Chemical class 0.000 claims description 3
- JSVCEVCSANKFDY-SFYZADRCSA-N carbacephem Chemical compound C1CC(C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)C)[C@H]21 JSVCEVCSANKFDY-SFYZADRCSA-N 0.000 claims description 3
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims description 3
- 229940124587 cephalosporin Drugs 0.000 claims description 3
- 150000001780 cephalosporins Chemical class 0.000 claims description 3
- UCKZMPLVLCKKMO-LHLIQPBNSA-N cephamycin Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](C)[C@]21OC UCKZMPLVLCKKMO-LHLIQPBNSA-N 0.000 claims description 3
- 229960003260 chlorhexidine Drugs 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229940124307 fluoroquinolone Drugs 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229940049954 penicillin Drugs 0.000 claims description 3
- 229940093158 polyhexanide Drugs 0.000 claims description 3
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 229960002180 tetracycline Drugs 0.000 claims description 3
- 229930101283 tetracycline Natural products 0.000 claims description 3
- 235000019364 tetracycline Nutrition 0.000 claims description 3
- 150000003522 tetracyclines Chemical class 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- 208000025865 Ulcer Diseases 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 231100000397 ulcer Toxicity 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims 2
- 206010011985 Decubitus ulcer Diseases 0.000 claims 1
- 230000003556 anti-epileptic effect Effects 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 239000000047 product Substances 0.000 description 40
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 30
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 14
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 229960004063 propylene glycol Drugs 0.000 description 12
- 235000013772 propylene glycol Nutrition 0.000 description 12
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 10
- 239000004358 Butane-1, 3-diol Substances 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 239000004146 Propane-1,2-diol Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- BTVWZWFKMIUSGS-UHFFFAOYSA-N 2-methylpropane-1,2-diol Chemical compound CC(C)(O)CO BTVWZWFKMIUSGS-UHFFFAOYSA-N 0.000 description 4
- 239000004875 Anti-Odour Agent Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 4
- GLOBUAZSRIOKLN-UHFFFAOYSA-N pentane-1,4-diol Chemical compound CC(O)CCCO GLOBUAZSRIOKLN-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
- DCTMXCOHGKSXIZ-UHFFFAOYSA-N (R)-1,3-Octanediol Chemical compound CCCCCC(O)CCO DCTMXCOHGKSXIZ-UHFFFAOYSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- 229940031723 1,2-octanediol Drugs 0.000 description 2
- UNVGBIALRHLALK-UHFFFAOYSA-N 1,5-Hexanediol Chemical compound CC(O)CCCCO UNVGBIALRHLALK-UHFFFAOYSA-N 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000004789 Rosa xanthina Nutrition 0.000 description 2
- 241000109329 Rosa xanthina Species 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 229940121357 antivirals Drugs 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 2
- FGNLEIGUMSBZQP-UHFFFAOYSA-N cadaverine dihydrochloride Chemical compound Cl.Cl.NCCCCCN FGNLEIGUMSBZQP-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 2
- HTXVEEVTGGCUNC-UHFFFAOYSA-N heptane-1,3-diol Chemical compound CCCCC(O)CCO HTXVEEVTGGCUNC-UHFFFAOYSA-N 0.000 description 2
- OGRCRHSHBFQRKO-UHFFFAOYSA-N heptane-1,4-diol Chemical compound CCCC(O)CCCO OGRCRHSHBFQRKO-UHFFFAOYSA-N 0.000 description 2
- NNYOSLMHXUVJJH-UHFFFAOYSA-N heptane-1,5-diol Chemical compound CCC(O)CCCCO NNYOSLMHXUVJJH-UHFFFAOYSA-N 0.000 description 2
- UQGLNXPQGUMNRU-UHFFFAOYSA-N heptane-1,6-diol Chemical compound CC(O)CCCCCO UQGLNXPQGUMNRU-UHFFFAOYSA-N 0.000 description 2
- SXCBDZAEHILGLM-UHFFFAOYSA-N heptane-1,7-diol Chemical compound OCCCCCCCO SXCBDZAEHILGLM-UHFFFAOYSA-N 0.000 description 2
- VUVZASHBYYMLRC-UHFFFAOYSA-N heptane-2,3-diol Chemical compound CCCCC(O)C(C)O VUVZASHBYYMLRC-UHFFFAOYSA-N 0.000 description 2
- XVEOUOTUJBYHNL-UHFFFAOYSA-N heptane-2,4-diol Chemical compound CCCC(O)CC(C)O XVEOUOTUJBYHNL-UHFFFAOYSA-N 0.000 description 2
- XTVHTJKQKUOEQA-UHFFFAOYSA-N heptane-2,5-diol Chemical compound CCC(O)CCC(C)O XTVHTJKQKUOEQA-UHFFFAOYSA-N 0.000 description 2
- OZIMXLFSRSPFAS-UHFFFAOYSA-N heptane-2,6-diol Chemical compound CC(O)CCCC(C)O OZIMXLFSRSPFAS-UHFFFAOYSA-N 0.000 description 2
- ZNZZFXONMYVVGZ-UHFFFAOYSA-N heptane-3,4-diol Chemical compound CCCC(O)C(O)CC ZNZZFXONMYVVGZ-UHFFFAOYSA-N 0.000 description 2
- BQWORYKVVNTRAW-UHFFFAOYSA-N heptane-3,5-diol Chemical compound CCC(O)CC(O)CC BQWORYKVVNTRAW-UHFFFAOYSA-N 0.000 description 2
- AVIYEYCFMVPYST-UHFFFAOYSA-N hexane-1,3-diol Chemical compound CCCC(O)CCO AVIYEYCFMVPYST-UHFFFAOYSA-N 0.000 description 2
- QVTWBMUAJHVAIJ-UHFFFAOYSA-N hexane-1,4-diol Chemical compound CCC(O)CCCO QVTWBMUAJHVAIJ-UHFFFAOYSA-N 0.000 description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 2
- QCIYAEYRVFUFAP-UHFFFAOYSA-N hexane-2,3-diol Chemical compound CCCC(O)C(C)O QCIYAEYRVFUFAP-UHFFFAOYSA-N 0.000 description 2
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 2
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 2
- POFSNPPXJUQANW-UHFFFAOYSA-N hexane-3,4-diol Chemical compound CCC(O)C(O)CC POFSNPPXJUQANW-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- NELAVKWPGRMFEQ-UHFFFAOYSA-N octane-1,4-diol Chemical compound CCCCC(O)CCCO NELAVKWPGRMFEQ-UHFFFAOYSA-N 0.000 description 2
- ZKRNQSNKDPEUOH-UHFFFAOYSA-N octane-1,5-diol Chemical compound CCCC(O)CCCCO ZKRNQSNKDPEUOH-UHFFFAOYSA-N 0.000 description 2
- GDUWKVCUIFEAGC-UHFFFAOYSA-N octane-1,6-diol Chemical compound CCC(O)CCCCCO GDUWKVCUIFEAGC-UHFFFAOYSA-N 0.000 description 2
- QUADBKCRXGFGAX-UHFFFAOYSA-N octane-1,7-diol Chemical compound CC(O)CCCCCCO QUADBKCRXGFGAX-UHFFFAOYSA-N 0.000 description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 2
- XMTUJCWABCYSIV-UHFFFAOYSA-N octane-2,3-diol Chemical compound CCCCCC(O)C(C)O XMTUJCWABCYSIV-UHFFFAOYSA-N 0.000 description 2
- HOWLAKMIIWUJEJ-UHFFFAOYSA-N octane-2,4-diol Chemical compound CCCCC(O)CC(C)O HOWLAKMIIWUJEJ-UHFFFAOYSA-N 0.000 description 2
- AZVKGHXATHHFRF-UHFFFAOYSA-N octane-2,5-diol Chemical compound CCCC(O)CCC(C)O AZVKGHXATHHFRF-UHFFFAOYSA-N 0.000 description 2
- ONGUKKAIGDNAGC-UHFFFAOYSA-N octane-2,6-diol Chemical compound CCC(O)CCCC(C)O ONGUKKAIGDNAGC-UHFFFAOYSA-N 0.000 description 2
- PAXWQLGKYISPNH-UHFFFAOYSA-N octane-2,7-diol Chemical compound CC(O)CCCCC(C)O PAXWQLGKYISPNH-UHFFFAOYSA-N 0.000 description 2
- UJWVPVVMYOBBIY-UHFFFAOYSA-N octane-3,4-diol Chemical compound CCCCC(O)C(O)CC UJWVPVVMYOBBIY-UHFFFAOYSA-N 0.000 description 2
- WYNVIVRXHYGNRT-UHFFFAOYSA-N octane-3,5-diol Chemical compound CCCC(O)CC(O)CC WYNVIVRXHYGNRT-UHFFFAOYSA-N 0.000 description 2
- BCKOQWWRTRBSGR-UHFFFAOYSA-N octane-3,6-diol Chemical compound CCC(O)CCC(O)CC BCKOQWWRTRBSGR-UHFFFAOYSA-N 0.000 description 2
- YOEZZCLQJVMZGY-UHFFFAOYSA-N octane-4,5-diol Chemical compound CCCC(O)C(O)CCC YOEZZCLQJVMZGY-UHFFFAOYSA-N 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 description 2
- GTCCGKPBSJZVRZ-UHFFFAOYSA-N pentane-2,4-diol Chemical compound CC(O)CC(C)O GTCCGKPBSJZVRZ-UHFFFAOYSA-N 0.000 description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- LBAYFEDWGHXMSM-UHFFFAOYSA-N butaneperoxoic acid Chemical compound CCCC(=O)OO LBAYFEDWGHXMSM-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000584 environmental toxicity Toxicity 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960001179 penciclovir Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
- A61L9/145—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes air-liquid contact processes, e.g. scrubbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
- A61L2209/20—Method-related aspects
- A61L2209/22—Treatment by sorption, e.g. absorption, adsorption, chemisorption, scrubbing, wet cleaning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/408—Virucides, spermicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Materials For Medical Uses (AREA)
- Sanitary Thin Papers (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Description
用語「用品」および「製品」は、本願において、同じ物を意味するように意図される。
本発明は、尿、糞便、下腿潰瘍滲出液、褥瘡潰瘍、血液、月経及び汗(perspiration)からのような哺乳動物からの臭いを減じ、及び/または除去するペンタン-1,5-ジオールを含む組成の使用に関するものである。
本発明はまた、ペンタン-1,5-ジオールを含む組成を含む製品において、上記で定義された吸収性及び/または衛生製品に関するものでもある。
使い捨てのナプキン上に、ペンタン-1,5-ジオール10%(v/v)及び30%(v/v)を含む活性溶液が、ナプキンの全部の領域が湿るまでスプレーされた。そのナプキンは、乾燥するまで、室温で放置された。その後、ナプキンは人間からの尿を取り除くために使用された。ナプキンによって尿を除去した後に、ナプキンから尿の匂いがしなかったことが分かり、ナプキンの消費者に好ましいものだった。対照として単独の水が使用された。水と活性溶液は同量使用された。
女性おむつ上に、実施例1と同じ溶液が、おむつが完全にその溶液によって充満されるまでスプレーされた。そのおむつは、乾燥のため室温で放置された。そのおむつの使用によって、尿の漏出疾患を持った女性は、長時間使用後でさえ、なんら匂いも気付くことがなかった。
実施例1と同じ方法、同じ溶液で、圧迫包帯にスプレーされた。
実施例1と同じ方法、同じ溶液で、圧迫包帯にスプレーされた。そのような圧迫包帯は、圧迫包帯として使用でき、下腿潰瘍や褥瘡潰瘍などの潰瘍に適用できる。
Claims (26)
- 哺乳動物の体液からの臭いを減じ、及び/または除去するために用いる吸収製品であって、
前記製品は活性溶液を含み、
上記活性溶液に含まれるジオール成分が、ペンタン-1,5-ジオールのみであり、
前記活性溶液に対する前記ペンタン-1,5-ジオールの含有割合が、10%(v/v)〜30%(v/v)である吸収製品。 - 前記哺乳動物の体液からの臭いが、尿、月経、糞便、下腿潰瘍滲出液、褥瘡潰瘍、血液および汗(perspiration)の群からから選ばれた臭いである、請求項1記載の吸収製品。
- 前記活性溶液が、抗菌性及び/または抗黴性成分をさらに含む、請求項1記載の吸収製品。
- 前記抗菌性及び/または抗黴性成分が、ペニシリン系、セファロスポリン系、カルバセフェム系、セファマイシン系、カルバペネム系、モノバクタム系、アミノグリコシド系、グリコペプチド系、キノロン系、テトラサイクリン系、マクロライド系、フルオロキノロン系、イミダゾール系、アリルアミン系、アシクロビル及びvectavirからなる群から選ばれた、請求項3記載の吸収製品。
- 前記活性溶液が、さらに防腐剤を含む、請求項1記載の吸収製品。
- 前記防腐剤が、ヨウ素、銀、銅、クロルヘキシジン、ポリヘキサンイド、アルギナート、亜鉛若しくは酸化亜鉛と他のビグアニド、酢酸および過酸化水素からなる群から選ばれる、請求項5記載の吸収製品。
- 前記活性溶液が、合成或いは半合成,若しくは天然同質の芳香供給物質を含む、請求項1記載の吸収製品。
- 前記吸収製品が、使い捨ての吸収シートである請求項1の吸収製品。
- 前記吸収製品が、空気清浄製品である請求項1の吸収製品。
- 前記吸収製品が、おむつである請求項1の吸収製品。
- 前記吸収製品が、下着パッドである請求項1の吸収製品。
- 前記吸収製品が、タンポンである請求項1の吸収製品。
- 前記吸収製品が、包帯である請求項1の吸収製品。
- 前記吸収製品が、圧迫包帯である請求項1の吸収製品。
- 前記吸収製品が、マスクである請求項1の吸収製品。
- 前記吸収製品が、空気ろ過道具である請求項1の吸収製品。
- 前記吸収製品が、生理用ナプキンである吸収製品。
- 前記吸収製品が、パンティー・シールドである請求項1の吸収製品。
- 前記吸収製品が、失禁パッドである請求項1の吸収製品。
- 前記吸収製品が、失禁道具である請求項1の吸収製品。
- 前記吸収製品が、外科用包帯である請求項1の吸収製品。
- 前記吸収製品が、絆創膏である請求項1の吸収製品。
- 前記吸収製品が、1つ以上の紙織物を含んでいる紙製品(ティシュペーパー、トイレットペーパー、ペーパータオル、ナプキンなど)である請求項1の吸収製品。
- 前記吸収製品が使い捨てナプキンである、請求項1記載の吸収製品。
- 前記吸収製品が女性おむつである、請求項1記載の吸収製品。
- 哺乳動物の体液からの臭いを減じ、及び/または除去するために用いる衛生製品であって、
前記製品は活性溶液を含み、
上記活性溶液に含まれるジオール成分が、ペンタン-1,5-ジオールのみであり、
前記活性溶液に対する前記ペンタン-1,5-ジオールの含有割合が、10%(v/v)〜30%(v/v)である衛生製品。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74029905P | 2005-11-29 | 2005-11-29 | |
SE0502610A SE529906C2 (sv) | 2005-11-29 | 2005-11-29 | Användning av en beredning innefattande pentan-1,5-diol för att minska eller förhindra odör |
US60/740,299 | 2005-11-29 | ||
SE0502610-9 | 2005-11-29 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014076011A Division JP2014210173A (ja) | 2005-11-29 | 2014-04-02 | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016073634A JP2016073634A (ja) | 2016-05-12 |
JP6149088B2 true JP6149088B2 (ja) | 2017-06-14 |
Family
ID=37905880
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008542748A Pending JP2009517152A (ja) | 2005-11-29 | 2006-11-28 | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 |
JP2014076011A Pending JP2014210173A (ja) | 2005-11-29 | 2014-04-02 | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 |
JP2015214004A Active JP6149088B2 (ja) | 2005-11-29 | 2015-10-30 | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008542748A Pending JP2009517152A (ja) | 2005-11-29 | 2006-11-28 | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 |
JP2014076011A Pending JP2014210173A (ja) | 2005-11-29 | 2014-04-02 | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090232761A1 (ja) |
EP (1) | EP1956903B1 (ja) |
JP (3) | JP2009517152A (ja) |
KR (1) | KR20080080508A (ja) |
AU (1) | AU2006319206A1 (ja) |
CA (1) | CA2630881A1 (ja) |
RU (1) | RU2455027C2 (ja) |
WO (1) | WO2007063065A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1956903B1 (en) * | 2005-11-29 | 2017-01-11 | Ambria Dermatology AB | Use of an absorption product comprising pentane-1, 5-diol as deodorant |
DE102007005334A1 (de) * | 2007-02-01 | 2008-08-07 | Beiersdorf Ag | Piperazinderivate in diolhaltigen kosmetischen Zubereitungen |
DE102007005336A1 (de) * | 2007-02-01 | 2008-08-07 | Beiersdorf Ag | UV-Filterkombination mit Piperazinderivaten |
DE102007005335A1 (de) * | 2007-02-01 | 2008-08-07 | Beiersdorf Ag | Lichtschutzzubereitung mit einer Kombination von Mikropigmenten |
DE102007032642B4 (de) * | 2007-07-11 | 2011-12-01 | Beiersdorf Ag | Verwendung von kurzkettigen Glykolen als antitranspirantwirksame Mittel |
SE533425C2 (sv) * | 2008-07-07 | 2010-09-21 | Ambria Dermatology Ab | Antimikrobiell sammansättning |
US9533479B2 (en) * | 2008-09-18 | 2017-01-03 | Medline Industries, Inc. | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
WO2010040418A1 (en) * | 2008-10-10 | 2010-04-15 | Sca Hygiene Products Ab | Absorbent article comprising acidic superabsorbent material and pentanediol |
DE102009004270A1 (de) | 2009-01-07 | 2010-07-08 | Beiersdorf Ag | Aromatische Diole als antitranspirantwirksame Mittel |
DE102009004269A1 (de) | 2009-01-07 | 2010-07-08 | Beiersdorf Ag | Diole als antitranspirantwirksames Mittel |
US9717818B2 (en) | 2009-05-08 | 2017-08-01 | Medline Industries, Inc. | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
AU2010202421B2 (en) | 2009-06-15 | 2014-05-08 | Gojo Industries, Inc. | Method and compositions for use with gel dispensers |
EP2470156A2 (de) * | 2009-08-26 | 2012-07-04 | Basf Se | Verwendung von 1,3-diolen als biozide |
WO2012108494A1 (ja) * | 2011-02-10 | 2012-08-16 | サントリーホールディングス株式会社 | 多価アルコールを含有する消臭剤 |
JP2013043861A (ja) * | 2011-08-24 | 2013-03-04 | Japan Enviro Chemicals Ltd | 尿臭抑制剤 |
AU2013222251B2 (en) | 2012-02-24 | 2016-07-28 | Gojo Industries, Inc. | Antimicrobial and foamable alcoholic compositions |
WO2018157936A1 (en) * | 2017-03-02 | 2018-09-07 | Essity Hygiene And Health Aktiebolag | Wipe with skin beneficial effect |
WO2018185508A1 (en) | 2017-04-04 | 2018-10-11 | Gojo Industries Inc | Methods and compounds for increasing virucidal efficacy in hydroalcoholic systems |
WO2021257922A1 (en) * | 2020-06-19 | 2021-12-23 | P2 Science, Inc. | New methods for hydrodealkenylation |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3762415A (en) * | 1968-03-06 | 1973-10-02 | Maxine B Money | Anti-bacterial menses absorbing pads |
GB1472536A (en) * | 1973-07-18 | 1977-05-04 | Unilever Ltd | Deodorant compositions |
US4820698A (en) * | 1985-11-04 | 1989-04-11 | The Procter & Gamble Company | Antimicrobial agents and process for their manufacture |
US5369129A (en) * | 1989-06-13 | 1994-11-29 | Hydro Pharma Ab | Preparation of topical treatment of infections caused by virus, bacteria and fungi |
JPH0451958A (ja) * | 1990-06-18 | 1992-02-20 | Mitsubishi Materials Corp | 循環式トイレ汚物処理剤 |
JPH08508423A (ja) * | 1993-03-31 | 1996-09-10 | ザ、プロクター、エンド、ギャンブル、カンパニー | ポジティブな香気シグナルを有する臭気抑制用の吸収物品 |
JP3562825B2 (ja) * | 1993-06-08 | 2004-09-08 | 日本化学工業株式会社 | 殺菌殺藻剤 |
EP0806195A1 (en) * | 1996-04-29 | 1997-11-12 | The Procter & Gamble Company | Breathable disposable absorbent article being capable of self-shaping in use |
JP3749785B2 (ja) * | 1998-03-10 | 2006-03-01 | アース製薬株式会社 | 脱臭効力増強剤およびこれを用いた脱臭剤 |
BR9900001A (pt) * | 1999-01-04 | 2000-08-29 | Johnson & Johnson Ind Com | Artigo absorvente descartável |
DE19924496A1 (de) * | 1999-05-28 | 2000-11-30 | Wella Ag | Desodorierende Wirkstoffkombination und deren Verwendung |
JP3855602B2 (ja) * | 2000-05-31 | 2006-12-13 | 大日本インキ化学工業株式会社 | 樹脂エマルジョンの製造法、塗料組成物および塗装方法 |
US20020161347A1 (en) * | 2001-02-15 | 2002-10-31 | Arie Besemer | Absorbent article |
JP5357369B2 (ja) * | 2001-03-02 | 2013-12-04 | 花王株式会社 | 介護臭用消臭剤 |
EP1269983B1 (de) * | 2001-06-22 | 2003-09-10 | Dragoco Gerberding & Co Aktiengesellschaft | Verwendung von 1,2-Decandiol gegen Körpergeruch verursachende Keime |
JP2003019190A (ja) * | 2001-07-10 | 2003-01-21 | Kao Corp | ペット排泄物用消臭剤 |
SE520236C2 (sv) * | 2001-10-26 | 2003-06-10 | Sca Hygiene Prod Ab | Inlägg till absorberande artikel med hudvårdande medel och distansskikt |
DE10206759A1 (de) * | 2002-02-19 | 2003-08-28 | Dragoco Gerberding Co Ag | Synergistische Mischungen von 1,2-Alkandiolen |
SE0301862D0 (sv) * | 2003-06-26 | 2003-06-26 | Jan Faergeman | Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier |
US7217690B2 (en) * | 2003-10-07 | 2007-05-15 | Kimberly-Clark Worldwide, Inc. | Compositions of sunflower trypsin inhibitors |
EP1956903B1 (en) * | 2005-11-29 | 2017-01-11 | Ambria Dermatology AB | Use of an absorption product comprising pentane-1, 5-diol as deodorant |
-
2006
- 2006-11-28 EP EP06830157.1A patent/EP1956903B1/en active Active
- 2006-11-28 US US12/085,582 patent/US20090232761A1/en not_active Abandoned
- 2006-11-28 RU RU2008126267/15A patent/RU2455027C2/ru active
- 2006-11-28 KR KR1020087012786A patent/KR20080080508A/ko not_active Application Discontinuation
- 2006-11-28 JP JP2008542748A patent/JP2009517152A/ja active Pending
- 2006-11-28 WO PCT/EP2006/069007 patent/WO2007063065A1/en active Application Filing
- 2006-11-28 CA CA002630881A patent/CA2630881A1/en not_active Abandoned
- 2006-11-28 AU AU2006319206A patent/AU2006319206A1/en not_active Abandoned
-
2014
- 2014-04-02 JP JP2014076011A patent/JP2014210173A/ja active Pending
-
2015
- 2015-10-30 JP JP2015214004A patent/JP6149088B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
AU2006319206A1 (en) | 2007-06-07 |
KR20080080508A (ko) | 2008-09-04 |
EP1956903B1 (en) | 2017-01-11 |
EP1956903A1 (en) | 2008-08-20 |
JP2009517152A (ja) | 2009-04-30 |
JP2014210173A (ja) | 2014-11-13 |
RU2008126267A (ru) | 2010-01-10 |
WO2007063065A1 (en) | 2007-06-07 |
CA2630881A1 (en) | 2007-06-07 |
JP2016073634A (ja) | 2016-05-12 |
RU2455027C2 (ru) | 2012-07-10 |
US20090232761A1 (en) | 2009-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6149088B2 (ja) | 消臭剤としてのペンタン−1,5−ジオールを含む組成の使用 | |
JP5073820B2 (ja) | 臭気制御系を有する使い捨て吸収性物品 | |
US8110215B2 (en) | Personal care products and methods for inhibiting the adherence of flora to skin | |
US10653811B2 (en) | Articles with odor-controlling composition | |
JP2021035495A (ja) | 臭気抑制組成物を含む物品 | |
KR20040030586A (ko) | 냉각 조성물 | |
JP4209062B2 (ja) | シクロデキストリンを含有した吸収性物品 | |
CN101316508A (zh) | 含有1,5-戊二醇的组合物作为除臭剂的用途 | |
MX2008006803A (es) | Uso como desodorante de una composicion que comprende pentano-1,5-diol | |
MXPA04000086A (es) | Uso de clorofila para el control de malos olores en articulos absorbentes desechables. | |
KR200411387Y1 (ko) | 나노실버가 도포된 생리대 | |
EP3326659B1 (en) | An absorbent article comprising an odor control mixture | |
JP2017108910A (ja) | 体液吸収性物品 | |
JP2023132192A (ja) | ウェットワイパー用薬液及びウェットワイパー | |
KR20130000428U (ko) | 한지를 이용한 일회용 한지흡수패드 | |
MXPA04000087A (es) | Emoliente para articulos absorbentes desechables. | |
WO2005067886A1 (en) | Odour absorbent materials | |
MX2013007903A (es) | Formula antirrozaduras a base de materiales naturales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160817 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160829 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170501 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170522 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6149088 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |